Crystallographic phasing of myristoyl-CoA:protein N-myristoyltransferase using an iodinated analog of myristoylCoA

Klaus Futterer, CL Murray, RS Bhatnagar, GW Gokel, JI Gordon, G Waksman

Research output: Contribution to journalArticle

5 Citations (Scopus)


Myristoyl-CoA-protein N-myristoyltransferase (Nmt; E.C. catalyzes the covalent attachment of myristate to the N-terminal glycine amine of many eukaryotic and viral proteins. The molecular structure of the ternary complex of Saccharomyces cerevisiae Nmt1p with a bound non-hydrolyzable myristoyl-CoA analog, S-(2-oxopentadecyl)-CoA, and a competitive peptidomimetic inhibitor, SC-58272, was solved to 2.9 Angstrom resolution by X-ray crystallography. The structure determination utilized diffraction data from an iodinated ternary complex in which a newly designed and synthesized compound, S-(13-iodo-2-oxotridecyl)-CoA, was substituted for S-(2-oxopentadecyl)-CoA. Replacing the two terminal fatty acid C atoms of myristate by iodine produced, under the same crystallization conditions, heavy-atom-derivatized crystals of defined site occupancy that were isomorphous to the native complex. This approach for obtaining experimental phase information can be extended to other crystal structures of protein-fatty acyl complexes. The synthesis of S-(13-iodo-2-oxotridecyl)-CoA and the phasing procedure are described.
Original languageEnglish
Pages (from-to)393-400
Number of pages8
JournalActa Crystallographica Section D Biological Crystallography
Issue number3
Publication statusPublished - 1 Mar 2001


Dive into the research topics of 'Crystallographic phasing of myristoyl-CoA:protein N-myristoyltransferase using an iodinated analog of myristoylCoA'. Together they form a unique fingerprint.

Cite this